Home Home Home Inbox Home Search

Event

Fevipiprant, a Potent Selective Antagonist of the Prostaglandin D2 Receptor 2, Modulates the Allergic Effector Unit Via Inhibition of Eosinophil Migration Towards Mast Cells [Board No. P1029]

Location: Board no. P1029
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Francesca Levi-schaffer

PhD
The Hebrew University of Jerusalem

Veit Johannes. Erpenbeck

MD, PhD
Novartis;Novartis Pharma AG

David Sandham

PhD
Novartis Institutes for Biomedical Research

Gerald Dubois

PhD
Novartis

Revital Shamri

Ph.D.
The Hebrew University of Jerusalem

View Abstract

Fevipiprant, a Potent Selective Antagonist of the Prostaglandin D2 Receptor 2, Modulates the Allergic Effector Unit Via Inhibition of Eosinophil Migration Towards Mast Cells

Parent Sessions

  • A32 - UPDATES IN ALLERGIC DISEASE
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search